Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 2 |
2012 | 1 |
2013 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Influence of Biomimetically Mineralized Collagen Scaffolds on Bone Cell Proliferation and Immune Activation.
Polymers (Basel). 2022 Feb 3;14(3):602. doi: 10.3390/polym14030602.
Polymers (Basel). 2022.
PMID: 35160591
Free PMC article.
(177)Lu/ (90)Y intermediate-affinity monoclonal antibodies targeting EGFR and HER2/c-neu: preparation and preclinical evaluation.
Beckford Vera DR, Eigner S, Eigner Henke K, Leyva Montaña R, Melichar F, Beran M.
Beckford Vera DR, et al. Among authors: beran m.
Recent Results Cancer Res. 2013;194:301-17. doi: 10.1007/978-3-642-27994-2_16.
Recent Results Cancer Res. 2013.
PMID: 22918766
Item in Clipboard
Preclinical evaluation of radiolabelled nimotuzumab, a promising monoclonal antibody targeting the epidermal growth factor receptor.
Barta P, Laznickova A, Laznicek M, Vera DR, Beran M.
Barta P, et al. Among authors: beran m.
J Labelled Comp Radiopharm. 2013 May 15;56(5):280-8. doi: 10.1002/jlcr.2988. Epub 2013 Jan 30.
J Labelled Comp Radiopharm. 2013.
PMID: 24285372
Item in Clipboard
Preparation and preclinical evaluation of 177Lu-nimotuzumab targeting epidermal growth factor receptor overexpressing tumors.
Vera DR, Eigner S, Henke KE, Lebeda O, Melichar F, Beran M.
Vera DR, et al. Among authors: beran m.
Nucl Med Biol. 2012 Jan;39(1):3-13. doi: 10.1016/j.nucmedbio.2011.07.001. Epub 2011 Sep 29.
Nucl Med Biol. 2012.
PMID: 21958849
Item in Clipboard
Preclinical evaluation of (177)lu-nimotuzumab: a potential tool for radioimmunotherapy of epidermal growth factor receptor-overexpressing tumors.
Vera DR, Eigner S, Beran M, Henke KE, Laznickova A, Laznicek M, Melichar F, Chinol M.
Vera DR, et al. Among authors: beran m.
Cancer Biother Radiopharm. 2011 Jun;26(3):287-97. doi: 10.1089/cbr.2010.0916. Epub 2011 Jun 28.
Cancer Biother Radiopharm. 2011.
PMID: 21711096
Item in Clipboard
Cite
Cite